By Sheri Kasprzak
New York, Jan. 10 - The Memorial Sloan-Kettering Cancer Center of New York offered $150 million of series 2012 taxable bonds, according to an official statement.
The bonds (Aa2/AA-/AA) are in addition to the $250 million of series 2011A taxable bonds sold by the center in December.
The new bonds have a 5% coupon priced at 101.932. The bonds are due July 1, 2042.
Goldman, Sachs & Co. was the senior manager for the sale, with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as the co-managers.
The December bonds are also due July 1, 2042 and have a 5% coupon priced at par.
Proceeds will be used to finance capital projects for the cancer center.
| Issuer: | Memorial Sloan-Kettering Cancer Center
|
| Issue: | Taxable bonds
|
| Amount: | $150 million
|
| Maturity: | July 1, 2042
|
| Coupon: | 5%
|
| Price: | 101.923
|
| Type: | Negotiated
|
| Underwriters: | Goldman, Sachs & Co. (lead), J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (co-managers)
|
| Ratings: | Moody's: Aa2
|
| Standard & Poor's: AA-
|
| Fitch: AA
|
| Pricing date: | Jan. 9
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
